Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti‐PD‐1
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.14678
Abstract: Pembrolizumab(®) , a first line immune checkpoint inhibitor, has shown good clinical activity with an acceptable safety profile, in the management of metastatic melanoma.(1, 2) We report a patient with metastatic melanoma, treated with anti-PD-1,… read more here.
Keywords: melanoma; regression; treated anti; metastatic melanoma ... See more keywords